Jefferies Group’s Medifast MED Stock Holding History

Jefferies Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,000	Closed	-$725K	–	2808
2019 Q3	$725K	Buy	+7,000	New	+$752K	0.01%	1681

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's MED Position: Q4 2019 in Review

Jefferies Group sold out of Medifast (MED) in Q4 2019, closing a stake of 3,069 shares — an estimated $318K sold.

Jefferies Group first reported a position in MED in Q2 2015 and held it in 8 quarters. The position peaked at $1.3M in Q1 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

Jefferies Group reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
Jefferies Group sold 3,069 Medifast shares in Q4 2019, an estimated $318K.
Jefferies Group first reported a position in Medifast in Q2 2015 and held it in 8 quarters.
Jefferies Group's Medifast position peaked at $1.3M in Q1 2019.
219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.